Survodutide is one of the most promising new weight-loss medications, combining GLP-1 and glucagon in a way we haven’t seen before. I break down how it works, what the early data shows, and why it could be a game-changer for both obesity and liver health.

I break down the SURMOUNT-5 trial comparing Zepbound (tirzepatide) and Wegovy (semaglutide) for weight loss. I cover the real numbers, side effects, and what this means for obesity treatment. These results could shift how we think about first-line options for chronic weight management.

Compare average weight loss on Wegovy vs. Zepbound with clear, week-by-week data from clinical trials. Learn what’s typical at each stage, why results may slow down over time, and what progress really looks like on these medications. Grounded in science, not opinions.

Wegovy may help reduce knee pain for people with osteoarthritis by lowering body weight and joint stress. This breakdown of the STEP 9 trial highlights how weight loss can improve joint function and reduce inflammation. A practical look at what the science means for managing knee OA.

Hair loss on GLP-1 medications like Ozempic, Wegovy, and Zepbound is often linked to rapid weight loss, nutrient deficiencies, and hormone changes. Find out why hair shedding happens and how to protect hair health while using weight loss medications.

Discover what the SURMOUNT-1 sub-study reveals about muscle loss on tirzepatide (Zepbound). Learn how much lean mass is typically lost during weight loss, what that means for your health, and the key strategies to protect your muscle while using weight-loss medications.

If you’ve heard claims about “natural Ozempic alternatives,” this is your reality check. I break down what the science actually says about the habits that can support appetite regulation, blood sugar control, and overall metabolic health. Whether you're on GLP-1 meds like Ozempic or just looking to support your body...

GLP-1 medications like Ozempic and Wegovy have sparked concern about their impact on diabetic retinopathy. I break down what diabetic retinopathy is, how it develops, and the real risks of rapid blood sugar changes. Learn how to protect your vision while managing diabetes or obesity effectively.

A new study has raised concerns about GLP-1s like Ozempic, Wegovy, and Mounjaro—but is the fear justified? I break down the real findings, the role of early detection bias, and what it actually means for GLP-1 users. Get the facts, not the fear.

Blurred vision after starting Ozempic, Wegovy, Mounjaro, or Zepbound? Discover the common reasons behind GLP-1-related vision changes, from blood sugar shifts to dehydration, and know when it’s time to speak to your doctor.